Adicet Bio Inc.

CG Oncology, Inc. achieved what no biopharmaceutical company has been able to do for more than two months – it went public in the US. The bladder cancer drug developer also launched the first initial

The founding of Altos Labs in January 2022, which launched with a record $3bn in venture capital funding from high-profile backers that reportedly include Amazon founder Jeff Bezos and billionaire e

Public biopharmaceutical company valuations have taken a sharp turn into the red in the US during the past month, plunging the industry’s market for initial public offering into a drought. This trend

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AiPharma Joins Effort To Develop Fujifi